BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12631108)

  • 1. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
    Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
    Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
    Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
    Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.
    Nagao S; Kusaka M; Nishii K; Marunouchi T; Kurahashi H; Takahashi H; Grantham J
    J Am Soc Nephrol; 2005 Jul; 16(7):2052-62. PubMed ID: 15888569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
    Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
    Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.
    Yamaguchi T; Reif GA; Calvet JP; Wallace DP
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F944-51. PubMed ID: 20810616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
    Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
    J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.
    Buchholz B; Klanke B; Schley G; Bollag G; Tsai J; Kroening S; Yoshihara D; Wallace DP; Kraenzlin B; Gretz N; Hirth P; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3458-65. PubMed ID: 21804086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.
    Belibi FA; Wallace DP; Yamaguchi T; Christensen M; Reif G; Grantham JJ
    J Am Soc Nephrol; 2002 Nov; 13(11):2723-9. PubMed ID: 12397042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease.
    Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP
    Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.
    Yamaguchi T; Wallace DP; Magenheimer BS; Hempson SJ; Grantham JJ; Calvet JP
    J Biol Chem; 2004 Sep; 279(39):40419-30. PubMed ID: 15263001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
    Spirli C; Morell CM; Locatelli L; Okolicsanyi S; Ferrero C; Kim AK; Fabris L; Fiorotto R; Strazzabosco M
    Hepatology; 2012 Dec; 56(6):2363-74. PubMed ID: 22653837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat.
    Nagao S; Nishii K; Yoshihara D; Kurahashi H; Nagaoka K; Yamashita T; Takahashi H; Yamaguchi T; Calvet JP; Wallace DP
    Kidney Int; 2008 Feb; 73(3):269-77. PubMed ID: 17943077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.
    Pinto CS; Raman A; Reif GA; Magenheimer BS; White C; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2016 Apr; 27(4):1124-34. PubMed ID: 26289612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease.
    Ecder T; Melnikov VY; Stanley M; Korular D; Lucia MS; Schrier RW; Edelstein CL
    Kidney Int; 2002 Apr; 61(4):1220-30. PubMed ID: 11918728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
    Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL
    Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.
    Nguyen AN; Jansson K; Sánchez G; Sharma M; Reif GA; Wallace DP; Blanco G
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F897-906. PubMed ID: 21697238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease.
    Parnell SC; Raman A; Zhang Y; Daniel EA; Dai Y; Khanna A; Reif GA; Vivian JL; Fields TA; Wallace DP
    Kidney Int; 2022 Nov; 102(5):1103-1114. PubMed ID: 35760151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.